IGF-1, IGF-2, and IGFBP-3 Levels and Colorectal Cancer Risk
Author Information
Author(s): Probst-Hensch N M, Yuan J-M, Stanczyk F Z, Gao Y-T, Ross R K, Yu M C
Primary Institution: Institute of Social and Preventive Medicine, University of Basel
Hypothesis
Are IGF-1, IGF-2, and IGFBP-3 concentrations associated with the risk of colorectal cancer in a cohort of Chinese men?
Conclusion
The study suggests that higher levels of IGF-2 and IGFBP-3 are associated with an increased risk of colorectal cancer.
Supporting Evidence
- The study involved 18,244 men without a history of cancer.
- IGF-2 and IGFBP-3 showed significant associations with colorectal cancer risk.
- Odds ratios for the highest quintile of IGF-2 and IGFBP-3 were 2.74 and 2.85, respectively.
Takeaway
This study found that certain proteins in the blood can help predict if someone might get colorectal cancer.
Methodology
Serum samples were collected from 18,244 men, and levels of IGF-1, IGF-2, and IGFBP-3 were measured in 135 men who developed colorectal cancer and 661 matched control subjects.
Limitations
The study is limited to a specific population and may not be generalizable to other groups.
Participant Demographics
Men aged 45-65 years from Shanghai, China, without a history of cancer.
Statistical Information
P-Value
0.0008 for IGF-2; 0.01 for IGFBP-3
Confidence Interval
95% Cl = 1.67–4.50 for IGF-2; 95% Cl = 1.69–4.81 for IGFBP-3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website